INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D. Akwatu Kenthi, MA Centre for Addictions and Mental Health CAMH

Similar documents
50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

B. PLAN OF ACTION FOR IMPLEMENTING THE GENDER EQUALITY POLICY

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

CICAD. Report on Drug Use in the Americas Executive Summary INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION

Senior Management Team Meeting Target setting in Latin America

Regional Update Pandemic (H1N1) 2009

Regional Update Pandemic (H1N1) 2009

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Regional Update Pandemic (H1N1) 2009 (March 15, h GMT; 12 h EST)

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009.

Current Status in Latin America

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators

Hemispheric Report. evaluation report on Drug control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

Special Topic. The ten leading causes of death in countries of the Americas

Pandemic (H1N1) (August 14, h GMT; 12 h EST) Update on the Qualitative Indicators

Regional Update Pandemic (H1N1) 2009 (December 1, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (January 19, h GMT; 12 h EST)

Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Influenza Vaccine Use In the Americas

Cervical Cancer Situation in Latin America and the Caribbean and PAHO/WHO Recommendations for the Way Forward

Deborah Chen MPH The Heart Foundation of Jamaica

Overview of the ProVac Initiative

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere,

WORLD HEALTH ORGANIZATION

ASSESSMENT OF IMPACTS OF AIR POLLUTION ON HEALTH

Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

Championing Health: Sustainable Development and Equity. PAHO Strategic Plan

Challenges for Latin America s. Information on Drug Consumption

Regional Update Pandemic (H1N1) 2009 (July 31, h GMT; 17 h EST) Update on the Qualitative Indicators Epidemiological Week 29 intensity

Regional Update Pandemic (H1N1) 2009 (May 24, h GMT; 12 h EST)

Zika virus (ZIKV) Latin America & Caribbean Situation Report #11 15 February 2017

CICAD Meeting with the Universities of the Americas Concerning the Drug Phenomenon Focusing on the Use of Scientific Evidence

Rubella and CRS Elimination in the Americas

The 9th Annual Dr. Lonnie E. Mitchell National Historically Black Colleges and Universities

Violence against women and girls in LAC and recent health system mandates

132nd SESSION OF THE EXECUTIVE COMMITTEE

Regional Update Influenza (August 16, h GMT; 12 h EST)

Economic and Social Council

ORGANIZATION OF AMERICAN STATES

REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

16 th session of the Working Group of Experts on People of African Descent Salle XXI, Palais des Nations, Geneva 30 March 2 April 2015

Healthy Caribbean 2012 Rallying for Action on NCDs

Investigating Disease Epidemics through Simulation with a focus on Chikungunya in the Americas

CICAD INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION. Secretariat for Multidimensional Security

countries do not have information available for this indicator.

XXVI CINP CONGRESS. mood disorders: The application. Gerhard Heinze M.D.

FERTILITY DECLINE AND PUBLIC POLICIES TO ADDRESS POPULATION RIGHTS: PERSPECTIVE FROM LATIN AMERICA

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD Secretariat for Multidimensional Security

References to Uruguay

Tobacco Control Report for the Region of the Americas

GUATEMALA S FAMILY PLANNING TRANSITION Successes, Challenges, and Lessons Learned for Transitioning Countries

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Taking vaccine effectiveness into public health decision making: The ProVac Example

Alcohol consumption and policies in the Americas: Status, challenges and opportunities

Translating Science to end HIV in Latin America and the Caribbean

RELAF SEMINAR 2010 Nenita La Rose Executive Director CHI

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Regional Update EW 31, 2014 Influenza and other respiratory viruses (August 12, 2014)

FORO: Enhancing Radiation Protection and Nuclear Safety in Ibero-America

_flu.asp. States. North. The Caribbean and (Cuba, South. South. B was observed.

Spanish Info Service for Rare Disease

CONFLICTS OF INTEREST RELATED TO ALCOHOL POLICY: WHAT CAN BE DONE?

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Regional meeting on implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC) in the Americas. Bogota, Colombia, 3 6 September 2013

The Dual Threat of Diabetes and Tuberculosis in the Americas

DRAFT SCHEDULE OF ACTIVITIES. 15:30-17:00 Registration of Participants 8th Floor Rubén Darío Room OAS GSB Washington, D.C., US

CICAD INTER AMERICAN DRUG ABUSE CONTROL COMMISSION. Secretariat for Multidimensional Security

42nd DIRECTING COUNCIL 52nd SESSION OF THE REGIONAL COMMITTEE

Regional Update EW 09 Influenza (March 15, h GMT; 12 h EST)

Eurasian Harm Reduction Association (EHRA) Strategic Framework

Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES

The Fifth Pan Commonwealth Forum on Open Learning Access to Learning for Development

DR. CARLOS ENCARNAÇÃO, MAYOR OF THE CITY OF COIMBRA

CD29/23 Page 2. (Eng.) EXPANDED PROGRAM ON IMMUNIZATION IN THE AMERICAS. Progress Report by the Director. 1. Background and Policy Basis

Regional Update EW 41 Influenza (October 25, h GMT; 12 h EST)

HEALTH ORGANIZATION HEALTH ORGANIZATION. regional committee. XLV Meeting. XXXVII Meeting Washington, D.C. September-October 1993

REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN

The Propylene Value Chain

Can Conditional Cash Transfers Play a Greater Role in Reducing Child Malnutrition? Lucy Bassett October 25, 2007

Nicaragua. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Geographical Symposium: ACP countries, South Africa, Latin America. Consultation on EU Agri-Food Export Interests Brussels, 25 June 2007

KATE STEPLETON. Curriculum Vitae

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

I. INSTITUTIONAL BUILDING / NATIONAL ANTI-DRUG STRATEGY

Trinidad and Tobago ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD)

References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS

Marta-Louise Ackers, a Robert E Quick, a Christopher J Drasbek, b Lori Hutwagner c and Robert V Tauxe a

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

TRADITIONAL, COMPLEMENTARY AND ALTERNATIVE MEDICINES AND THERAPIES

MDG STATISTICAL PROGRAMME IN LAC SESSION 1: REGIONAL MDG STATISTICAL PROGRAMMES. Daniel Taccari/ Statistics Division ECLAC

Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015

Zika Operation: IMPACT IN THE AMERICAS. Americas Regional Office

Transcription:

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FORTY-EIGHTH REGULAR SESSION December 6-8, 010 Washington, D.C. OEA/Ser.L/XIV..48 CICAD/doc.187/10 3 December 010 Original: English THE CICAD-CAMH PARTNERSHIP EXPERIENCE FOR THE IMPLEMENTATION OF INTERNATIONAL RESEARCH CAPACITY-BUILDING AKWATU KENTHI, CAMH, CANADA The Executive Secretariat of CICAD-CAMH CAMH Partnership Experience: An International Research Capacity Building Program for Health Related Professionals to Study the Drug Phenomenon in Latin America and the Caribbean Akwatu Kenthi, MA Centre for Addictions and Mental Health CAMH Maria da Gloria Wright, PhD Inter-American Drug Abuse Control Commission- OAS/SMS/CICAD 1

Context The current global context requires specialized professionals able to analyze problems and propose solutions and/or strategies with national and international perspectives based on scientific data. Most OAS member states do not have a cadre of professionals with scientific knowledge and research experience on drugs and related problems to work at national drug commissions, research centers, or academia. Generally, countries have not established programs or long-term plans to do research on the drug phenomenon. There are few initiatives to manage the incorporation of research findings into national drug control policies. Context () To alleviate the problem, developing countries have partnered with developed countries to design strategies for scientific advancement in the study of the drug phenomenon. OAS/Executive Secretariat of CICAD has been developing strategies to assist OAS member states to strengthen institutional capacity and human resources related to security, moneylaundering and drug demand reduction. The International Research Program for Health and Related Areas Professionals to Study the Drug Phenomenon in Latin America and the Caribbean -IRCBP" is an initiative of OAS/Executive Secretariat of CICAD in partnership with the Centre for Addiction and Mental Health (CAMH) Toronto/Canada, to train professionals and address this problem.

Center for Addiction and Mental Health - CAMH CAMH areas of specific expertise School Curriculum Web based curriculum resource for teachers of Grades 1 to 1 with lessons plans and support materials for Health and Physical Education expectations related to substance use (grades 1 to 10) and mental health (grades 11 & 1) Talking about Mental Illness (TAMI) An anti-stigma program for secondary school students Youth & Drugs & Mental Health Educational Package Educational Package for working with diverse youth who present concurrent mental health and substance use concerns. School Policy Work related to: Curriculum development and teacher training, student support and campus policies for drugs, alcohol, and violence Ontario Student Drug Use Survey (OSDUS) Every years this report describes the rates and patterns of drug use among students grades 7 to 13 in Ontario and documents changes in both since 1977. Preventing Substance Use Problems Among Young People: A Compendium of Best Practices A document by CAMH, the Canadian Centre for Substance Abuse and the Canadian Association for School Health that features effective substance abuse prevention programs for youth. 3

Other CAMH collaborations 1997 - CARIAD - CAMH annual -week basic training in alcohol and other drug treatment for health and allied professionals in English Caribbean region + advanced courses for specialized topics 003 - Primary Care Capacity Building: Mexico, Nicaragua, Brazil, Chile 008 - Evaluation Capacity Building (Chile, Brazil, Trinidad & Tobago, Mexico) 009 - PAHO-CAMH Leadership capacity building program. Others: - Collaboration on Alcohol Policy Development (Chile), Drug research (Brazil) - Evaluation of Youth Addiction Treatment Services (Chile) - 010: Haiti needs assessment and program planning International Research Program for Health and Related Areas Professionals to Study the Drug Phenomenon in Latin America and the Caribbean 4

Program Objectives Create a cadre of health and related areas professionals with scientific and technical research knowledge to enable scientific advances in the field of the drug phenomenon - drug demand reduction area; Support with scientific evidence the development of public policy, decisionmaking, management and evaluation of programs and projects; Enable the exchange of Latin America researchers with Canadian researchers in the area of the drug phenomenon. General characteristics Number of Hours Typo of Program Length Faculty Target Language Typo of research Funding Association 466 hours (Part I) 650 hours (Part II ) Total: 1116 hours Post-doctorate (participants with PhD) Specialization (participants with MSc) 1 year, divided as follows: Part I Theory and Practice of Program s Content Part II Distance Learning Tutorial (country of origin) CAMH, University of Toronto, and Executive Secretariat of CICAD/OEA Health and related areas professionals English Multicentric based in a central drug theme chosen with the group, along with Inter-American Drug Control Commission s priorities, countries priorities and interest of participants Government of Canada Executive Secretariat of CICAD and the University of Alberta/Canada (first edition); subsequent editions with the Centre for Addictions and Mental Health- CAMH /Toronto/Canada 5

Curriculum Modules Pre-Module I II III IV V VI VII (i) (ii) English language and cultural aspects of Canadian society; Seminar for selection of central research theme for the multicentric drug research proposal Drug problems in the Americas and the World International Health and Drug Phenomenon in the Americas and the World Research Methodology (qualitative and quantitative) Creation and management of research groups and exchange programs in the Americas Communication and dissemination of multicentric research results Multicentric drug research proposal Themes Implementation of the multicentric research project in the country of origin Total Hours 80 30 0 0 10 0 16 160 650 1116 Participants per countries during 003-010 Uruguay Paraguay Panama Peru Nicaragua Mexico Jamaica Honduras Guatemala El Salvador Ecuador Costa Rica Colombia Chile Brasil Argentina 1 3 1 1 3 6 3 5 8 5 15 0% % 4% 6% 8% 10% 1% 14% 16% 6

Academic areas represented during 003-010 Psychology 15% Medicine 15% Public Health 5% Social Services % Education 3% Law 5% Stadistics % Nursing 53% Considerations about multicentric studies Characteristics Definition General Coordination Ethical Committee Management and monitoring Activities Funding Advantages Controlled studies, carried out in cooperation among a number of countries and/or organizations to reach specific variables, results and comparisons. Generally carried out by a central organization (international or national) Presentation of the study proposal for approval by the respective Ethical Committee. National, regional and local levels Administrative, training, data collection, statistics, technical reports, publication and dissemination of results. Cooperation agreements signing among participant organizations Relevant thematic for several countries and region. Collaboration among researchers through design, implementation, publication and dissemination. Cooperation among participant countries and organizations. Transfer/exchange of resources and mutual accountability. Foster the set up of researchers network. Allow the use of data for dissertations (masters and doctorates) 7

Multicentric studies Program Studies 003-004. Women, Drugs and Violence in Latin America (Exploratory Study I). 006-007. Illicit Drug Use in Seven Latin American Countries: Critical Perspectives of Family and Familiars. 007-008. University Student s Perceived Norms about Peers and Drug Use: A Multicentric Study from Five Latin America Countries. 008-009. Simultaneous Poly-Drug Consumption among Undergraduate University Students in Six Latin American Countries and in One Caribbean Country: Gender, Legal and Social Implications. 009-010. A Multicentric Study of Co-morbidity Between Psychological Distress and Drug use among Patients in Treatment Centers, in Seven Countries of Latin America and One Country in the Caribbean: Policy and Program Implications Program Studies 010-011. Drug Use Among Students and Its Relationship with Maltreatment During Childhood in Seven Universities in Latin America and the Caribbean. Other Studies 005-007. Drugs, Women and Violence in 1 Countries of the Americas. CICAD/SENAD/Brazil. (Exploratory Study II). 009-01. The Nexus between Drugs and Violence in the Americas: A Gender Perspective (CICAD/CAMH/10 countries. ( final study). 006-Present. Illicit Drug Use in Canada-Toronto: Critical Perspectives of Family and Familiars. Program s results and products Results Group 003-004 Group 006-007 Group 007-008 Group 008-009 Group 009-010 Sub-Total Group 010-011 Total Participants 11 graduates 10 graduates 10 graduates 10 graduates 10 graduates 51 Graduates 10 in process of data collection and analysis for starting preparing reports and papers for publication 61Graduates Products Three first groups have already published 35 articles in an international journal 31 posters were presented at OAS/CICAD University Meetings 4 posters were presented at NIDA/NIH International Research Forum (008 posters; 009 posters). 8

Challenges The annually request for financial support to the Canadian Government prevent a long-term programming. The request should be made for a longer period, for example 5 years; Latin American university faculty experience with multicentric research is limited; When participants return to their country they must face a workload that might cause conflicts with the multicentric research implementation; In several Latin American universities the Ethics Committee approval process is very slow, delaying the start of the research data collection. Program s impact Professional development: Post-doctoral degree for participants with PhD and specialist degree for participants with master; Presentation of poster and other results of the multicentric research at national and international conferences and OAS/CICAD meetings; Publication of scientific articles on the multicentric research results in international and national journals; Some participants have become members of the Latin America Network of Researchers on Drugs; Point of reference in the country to participate in future national studies on drug led by Executive Secretariat of CICAD/OID; Some participants have became leaders in the drug field, at universities and to their respective national drug commission; 9

Program s impact () University: Postgraduate and undergraduate strengthened; Creation of drug research groups at the universities; Opportunities for exchange faculty, researchers and graduate students among participating countries of the program and also with Canada. Drug Demand Reduction: Increase of scientific production of research studies in the area of drug demand reduction; Research findings provide support for evidence practice and policy development. Perspectives The Government of Canada should support for an additional 5 years the Executive Secretariat of CICAD-CAMH International Research Program in order to consolidate a group of researches in participating countries; Creation of an alumni association to support new opportunities for research exchange programs and future multicentric drug studies; Program alumni should continue to publish results of their multicentric study carried out during the Program; New multicentric drug studies should be proposed by Executive Secretariat of CICAD-CAMH researchers and Program alumni; Every 5 years Executive Secretariat of CICAD-CAMH should have an external auditing to estimate the Program s impact on the scientific advance of the area of drug reduction in Latin America. 10

THANKS! Akwatu Khenti, MA Akwatu_Khenti@camh.net Maria da Gloria Wright, PhD gwright@oas.org 11